Study: Reducing Off-Label Use of Antipsychotic Meds May Save Money - Gant Daily

Study: Reducing Off-Label Use of Antipsychotic Meds May Save Money Gant Daily Researchers say that 57.6 percent of patients prescribed antipsychotic medications in data from 2003 did not have schizophrenia or bipolar disorder, the conditions for which the drugs were approved for use. Use of medication for treatments that is not ... and more »

Connecticut To Share In $1.5 Billion Drug Settlement - Connecticut Law Tribune

Connecticut To Share In $1.5 Billion Drug Settlement Connecticut Law Tribune Depakote is approved by the FDA for treatment of seizure disorders, mania associated with bipolar disorder and to prevent migraine headaches. But according to officials, Abbott also marketed the drug for behavioral disturbances in dementia patients, ... Business Week Article States That Manufacturer of Depakote Agrees to Pay $1.6 ...Albany Times Union all 4 news articles »